Search Results 1951-1960 of 17111 for Single+nucleotide+polymorphisms

  1. Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE) - Mayo Clinic

    A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living ...

  2. Clinical trials - Oncology (Medical)

    The purpose of this study is to estimate the rate of sustained MRD negativity (MRD negative status at any point, with a repeated MRD negative status one year ...

  3. Clinical trials - Oncology (Medical)

    The purpose of this study is to estimate the rate of sustained MRD negativity (MRD negative status at any point, with a repeated MRD negative status one year ...

  4. Clinical trials - Oncology (Medical)

    * Visit the clinic three times for the first week of cycle one, then once a week for the remaining 7 weeks of cycle 1 for check-ups and tests. * For cycles ...

  5. Clinical trials - Oncology (Medical)

    ... (single or multiple) and stem cell transplant. Adipose-Derived Mesenchymal Stem Cells (AMSCs) For Recurrent Glioblastoma. Jacksonville, Fla. This study aims ...

  6. A Study to Analyze Whole Methylome for Identification of Epigenetic Variations in Undiagnosed Congenital Disorders - Mayo Clinic

    A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living ...

  7. Publications - David M. Nestler, M.D., M.S. - Mayo Clinic

    Impact of scribes on emergency department patient throughput one year after implementation. Am J Emerg Med. 2017 Feb; 35 (2):311-314 Epub 2016 Nov 05. View ...

  8. A Study to Evaluate Pevonedistat, Azacitidine (or Decitabine), and Venetoclax (PAVE) to Treat Acute Myelogenous Leukemia (AML) Patients - Mayo Clinic

    A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living ...

  9. A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy Duration - Mayo Clinic

    A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living ...

  10. Publications - Amjad N. Kanj, M.D., M.P.H. - Mayo Clinic

    PLoS One. 2021; 16 (9):e0255981 Epub 2021 Sept 16. View PubMed; Chehab O, Morsi RZ, Kanj A, Rachwan RJ, Pahuja M, Mansour S, Tabaja H, Ahmad U, Zein SE, Raad ...